Department of Conservative Dentistry, School of Dentistry, Rio Grande do Sul Federal University (UFRGS), 2492 Ramiro Barcelos Street, Porto Alegre, RS, 90040-060, Brazil.
Clin Oral Investig. 2023 May;27(5):1885-1897. doi: 10.1007/s00784-023-04979-3. Epub 2023 Mar 29.
The aim of the present umbrella review was to answer the following question: "Does the use of NSAIDs as premedication increase the efficacy of the standard inferior alveolar nerve block on teeth with symptomatic irreversible pulpitis?"
Systematic reviews with and without meta-analyses that evaluated the influence of premedication on anesthetic efficacy of the inferior alveolar nerve in symptomatic irreversible pulpitis of mandibular molars were searched in six electronic databases (MEDLINE/PubMed, Scopus, Web of Science, Cochrane Library, EMBASE, and Grey Literature Reports), without the restriction of language or year of publication. A Measurement Tool to Assess systematic Reviews (AMSTAR 2) was used to evaluate the quality of the included studies.
Twelve systematic reviews were included. Only one did not perform a meta-analysis. The AMSTAR 2 overall confidence ranged from very low to high. In general, the main findings of the systematic reviews were that non-steroidal anti-inflammatory drugs (e.g., ibuprofen, oxicam, diclofenac, association of ibuprofen with acetaminophen, and ketorolac) increased the success rate of the inferior alveolar nerve block.
From the "very low" to "high"-quality evidence available, this umbrella review concluded that NSAIDs as premedication acts through cyclooxygenase pathways and block the synthesis of specific prostaglandins that complicate the mechanism of action of the anesthesia, improving its success rate.
Non-steroidal anti-inflammatory drugs can increase the success rate of the anesthetic technique of inferior alveolar nerve block efficacy in situations of mandibular molars with symptomatic irreversible pulpitis.
本综述的目的是回答以下问题:“使用 NSAIDs 作为预处理是否会增加有症状的不可复性牙髓炎下颌磨牙标准下齿槽神经阻滞的疗效?”
在六个电子数据库(MEDLINE/PubMed、Scopus、Web of Science、Cochrane Library、EMBASE 和灰色文献报告)中搜索了评估预处理对下颌磨牙有症状的不可复性牙髓炎下颌神经麻醉效果影响的有和无荟萃分析的系统评价,未对语言或出版年份进行限制。使用评估系统评价的测量工具(AMSTAR 2)来评估纳入研究的质量。
共纳入 12 项系统评价。只有一项没有进行荟萃分析。AMSTAR 2 的整体可信度从极低到高不等。总的来说,系统评价的主要发现是,非甾体抗炎药(如布洛芬、昔康、双氯芬酸、布洛芬与对乙酰氨基酚的联合用药和酮咯酸)增加了下齿槽神经阻滞的成功率。
从现有“极低”到“高”质量证据来看,本综述总结认为,NSAIDs 作为预处理通过环氧化酶途径发挥作用,并阻断特定前列腺素的合成,这会使麻醉作用机制复杂化,从而提高其成功率。
非甾体抗炎药可增加有症状的不可复性牙髓炎下颌磨牙下齿槽神经阻滞麻醉技术的成功率。